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Adiponectin is an abundant serum adipokine secreted exclu-
sively from differentiated adipocytes, which plays an impor-
tant role in regulating insulin sensitivity. The dynamics of
circulating adiponectin concentrations have yet to be system-
atically investigated. We sought to determine whether serum
adiponectin levels exhibit diurnal or ultradian rhythms in
healthy normal-weight men and to compare the 24-h profile of
adiponectin fluctuations with those of leptin, leptin-binding
protein (sOB-R), and cortisol.
We collected blood samples at 15-min intervals over 24 h
from six subjects receiving an isocaloric diet, and we mea-
sured adiponectin, leptin, sOB-R, and cortisol levels. Fourier
and cross-correlation analyses were performed on these time
series to study diurnal variations, and the Cluster7 program
was used for pulsatility analysis.
Circulating adiponectin and sOB-R levels exhibited ultra-
dian pulsatility as well as a diurnal variation with a signifi-
cant decline at night, reaching a nadir in the early morning.
The 24-h variations of serum adiponectin and sOB-R were
nearly identical and followed those of cortisol after a few
hours, but were out-of-phase with leptin diurnal rhythms.
These data suggest that adiponectin and sOB-R levels might
be influenced by common regulatory factors and challenge
the notion that cortisol may have a direct inhibitory effect on
adiponectin in humans. (J Clin Endocrinol Metab 88:
2838–2843, 2003)
A
VARIETY OF endocrine systems exhibit circadian
(24 h) and ultradian (24 h) variations. Although
these features were first demonstrated for hormones of the
hypothalamic-pituitary axis, similar patterns apply to other
hormones as well (1). Peripheral insulin action, for example,
shows diurnal variations in part mediated by serum cortisol,
which is known to have circadian and ultradian rhythmicity
under hypothalamic-pituitary control (1, 2).
Adipose tissue also has the capacity to regulate insulin
sensitivity through several proteins (adipokines) that are
secreted into the circulation (3). Accumulating evidence
shows that adiponectin, an abundant serum adipokine ex-
pressed and secreted exclusively from differentiated adipo-
cytes (4, 5), plays an important role in insulin sensitivity.
Adiponectin knockout mice develop insulin resistance (6),
whereas adiponectin administration improves insulin resis-
tance in obese mice with low circulating adiponectin levels
(7). In humans, serum adiponectin is decreased in obesity
and diabetes (8, 9), and low levels precede and correlate with
the decline of insulin sensitivity (10, 11). Leptin, another
intensively studied adipokine, has an important role in reg-
ulating energy homeostasis (12) as well as insulin sensitivity
in rodents and leptin-deficient humans with congenital lip-
odystrophy (7, 13, 14). The biological activity of leptin is
modulated by the soluble cleaved extracellular part of the
leptin receptor (sOB-R), which is its main binding protein in
the serum (15). Although the tissue source(s) and the exact
molecular basis of its production remain to be fully eluci-
dated, recent evidence suggests that sOB-R is secreted by
adipose tissue alone or in combination with leptin (16–19).
Serumleptinlevelshavebeenreportedtohaveultradianand
circadian rhythmicity (20–22), whereas sOB-R shows a di-
urnal variation opposite to that of leptin (23).
The dynamics of circulating adiponectin concentrations
have yet to be systematically investigated. In this study, we
sought to determine whether serum adiponectin levels ex-
hibit a diurnal rhythm or pulsatile patterns of secretion in
healthy normal-weight men. Because leptin and cortisol in-
fluence insulin sensitivity and have well established circa-
dian and ultradian rhythmicity, we also compared the di-
urnal adiponectin profile with those of leptin, sOB-R, and
cortisol.
Subjects and Methods
Subjects
Six normal-weight healthy Caucasian men (mean age, 20.3  0.6 yr;
mean body mass index, 22.8  0.9 kg/m
2) gave informed consent to
participate in this study, which was approved by the Institutional Re-
view Board at the Beth Israel Deaconess Medical Center. Subjects were
screened for any significant medical history based on physical exami-
nation and routine laboratory tests. None of the subjects had abnormal
glucose tolerance based on screening serum glucose measurements
(mean random serum glucose, 75.7  13.4 mg/dl).
Twenty-four-hour blood sampling protocol
Subjects were acclimatized to a research bed in the General Clinical
Research Center for 48 h before the study and placed on an isocaloric
Abbreviations: CV, Coefficient of variation; sOB-R, soluble leptin
receptor.
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2838weight-maintainingdietwithbreakfastat0800h(20%ofcalories),lunch
at 1300 h (35% of calories), dinner at 1800 h (35% of calories), and snack
at 2200 h (10% of calories), which was followed for the entire duration
of the study. Subjects were exposed to light from 0700 h to 2300 h and
were in the dark from 2300 h to 0700 h. They were not allowed to do
strenuousactivityduringtheday,butotherwiseactivitywasnotlimited.
On the third day, starting at 0830 h, blood samples were collected every
15 min for 24 h (a total of 97 samples per subject) through an iv catheter
inserted in an antecubital vein. During the night, blood samples were
drawn outside the subjects’ rooms to avoid disturbing their sleep. Sam-
ples were centrifuged after collection and stored frozen at 80 C until
assayed for adiponectin, leptin, sOB-R, and cortisol.
Hormone measurements
Serum adiponectin levels were measured using a RIA (Linco Re-
search, Inc., St. Charles, MO) with a sensitivity of 1 ng/ml and an
intra-assaycoefficientofvariation(CV)of6.6%.Serumleptinlevelswere
measured using a RIA (Linco Research, Inc.) with a sensitivity of 0.5
ng/ml and intra-assay CV of 8.3%. Serum sOB-R levels were measured
usingacommerciallyavailableELISA(BioVendorLaboratoryMedicine,
Brno, Czech Republic), with a sensitivity of 0.8 ng/ml and intra-assay
CV between 5.5% and 6.6%. Serum cortisol levels were measured using
a RIA (Diagnostic Systems Laboratories, Inc., Webster, TX) with a sen-
sitivity of 0.5 g/dl and intra-assay CV between 5.3% and 8.4%. To
minimize assay variability, all samples for each subject were assayed at
the same time.
Diurnal variability analysis
Twenty-four-hour time series analysis. Fourier analysis (24) was applied to
the 24-h analyte time series to study fluctuations on selected time scales.
Serum levels of adiponectin, leptin, sOB-R, and cortisol for each subject
were first low-pass filtered over a frequency range of 0–0.1 cycles/h to
extract the low-frequency components. These low-pass filtered time
series were used to study the long-term (24 h) variations. Each filtered
dataset was rescaled so that the 24-h average was set equal to 100%, and
data at each time point were defined as a percentage of the 24-h average.
Group averages over all six subjects were then calculated for each of the
four analytes–adiponectin, leptin, sOB-R, and cortisol. The acrophase
and nadir of the diurnal variations were defined as the times of occur-
rence of the maximum and minimum values of these group averages,
respectively.
Cross-correlation analysis. To assess the temporal relationships of diurnal
variations among the four analytes, we applied standard cross-corre-
lationmeasurements(24)onthefollowingpairsoflow-passfilteredtime
series from each subject: adiponectin vs. leptin, adiponectin vs. sOB-R,
adiponectin vs. cortisol, leptin vs. cortisol, sOB-R vs. cortisol, and leptin
vs. sOB-R. The cross-correlation functions were then averaged over all
six subjects, and the lag relationships among all four analytes were
calculated. We also calculated Spearman’s correlation coefficients be-
tween simultaneous values of the four analytes using averaged 24-h
profiles over all six subjects.
Ultradian variability (pulsatility) analysis
Cluster7, a computerized algorithm (25), was used to identify puta-
tive pulses in the 24-h adiponectin, leptin, sOB-R, and cortisol time
series. Pulses are defined by this program as significant increases fol-
lowed by significant decreases when analyzed using pooled t testing. To
diminish the false-positive rate, several test parameters are operator-
selected, including the intra-assay CV, the number of degrees of free-
dom, the width of the nadir and peak clusters, as well as the level of
significance of the t statistic score. For the 15-min sampling procedure
used in the study, we considered peaks being represented by one time
point, and nadirs by two consecutive time points. We used a conser-
vative intra-assay CV of 10%, chosen to be higher than those of each of
the four assays. We analyzed the 24-h pulsatility patterns of the four
analytes using different t statistic scores and report herein data obtained
with a t statistic value of 2, which resulted in cortisol and leptin pul-
satility close to previously reported patterns (1, 21, 22). To further val-
idate that the pulsatile peaks detected by the Cluster algorithm are not
simply due to random noise with a circadian variation, we tested the
algorithm on surrogate data obtained by superimposing random Gauss-
ian noise with 8% CV in the low-pass filtered adiponectin time series.
Pulses were characterized with the following parameters, reported as
mean  sem: peak frequency (number of peaks per 24 h), mean peak
duration (minutes), mean interval between peaks (minutes), mean peak
height expressed as absolute value and percentage from the preceding
nadir value, and mean value between peaks. Because one subject (no. 3)
had multiple consecutively missing values, only five of the six 24-h
profiles could be used to calculate mean pulse parameters.
Results
Diurnal variability analysis
Twenty-four-hour time series analysis. Figure 1 shows the 24-h
serum adiponectin, leptin, sOB-R, and cortisol profiles of
each subject plotted at 15-min intervals (not filtered). Visual
inspection of these time series reveals a complex pattern of
fluctuations. Figure 2 presents the low-pass filtered values
averaged for all six subjects and suggests diurnal patterns.
Figure3summarizesallfourserumconcentrationprofileson
the same graph. Table 1 gives the diurnal variation param-
eters of the four analytes.
Adiponectin. Serum adiponectin showed a clear diurnal vari-
ation characterized by a nocturnal decline starting in the late
eveningandcontinuingthroughoutthenighttoreachanadir
in the early morning (Table 1 and Fig. 2). Adiponectin levels
were higher during the day, with a peak in the late morning.
After peak levels were reached, there was minimal daytime
variation, with adiponectin levels decreasing slightly during
the early afternoon and then plateauing until late evening.
The peak levels represented a 14.9  3.7% increase from the
24-h mean, whereas the trough levels represented a 22.6 
3.1%decreasefromthe24-hmeanadiponectinconcentration.
The maximum diurnal variation calculated as the difference
between the mean peak and trough values was 1.7  0.1
g/ml, representing 37.5  6.8% of the mean 24-h adiponec-
tin level.
Adiponectin vs. leptin and sOB-R. Serum adiponectin and lep-
tin showed out-of-phase 24-h profiles (Table 1 and Fig. 3). A
progressiveincreaseofleptinoccurredduringtheday,reach-
ing peak levels in the evening or early night. Leptin levels
then declined during the night to a nadir in the early morn-
ing. In contrast to the adiponectin-leptin relationship, adi-
ponectinandsOB-Rprofilesshowedastrikingsimilarityand
trackedeachothercloselyover24h,reachingtheirminimum
andmaximumlevelsataboutthesametime.ThepeaksOB-R
level was attained around noontime, whereas the nadir was
observed in the early morning. SOB-R had slightly larger
percentage variations compared with adiponectin levels at
all times (Table 1 and Fig. 3).
Adiponectin vs. cortisol. These two hormones had similar pro-
files; adiponectin, however, showed smaller percentage am-
plitude changes over the entire 24-h period (Table 1 and Fig.
3). Cortisol levels progressively increased during the morn-
ing with peak levels in the late morning, followed by a
continuous decline during the rest of the day with a nadir in
the early night. Although adiponectin and cortisol reached
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during the day, in contrast to cortisol, and reached its nadir
2 h after cortisol in the early morning hours.
Comparison of all four time series showed that serum
adiponectin and sOB-R reached maximum levels in the late
morning at approximately the same time with cortisol, and
4–5 h after the minimum leptin levels were observed. Adi-
ponectin and sOB-R reached minimal levels early in the
FIG. 1. Serum adiponectin, leptin, sOB-R, and cortisol levels for each of the six subjects sampled every 15 min over a 24-h period starting at
0830 h. The vertical axis scales differ between subjects due to individual variability in the ranges of these hormone levels. Missing data points
were interpolated using a cubic spine interpolation and are indicated by open circles.
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8 h after maximum leptin levels were observed.
Cross-correlation analysis. Table 2A presents results of
the cross-correlation analysis. Maximum values of the
mean cross-correlation coefficients were observed when the
long-term sOB-R fluctuation led adiponectin by 30 min in
average, when adiponectin led leptin by 3 h and 15 min, and
when sOB-R led leptin by 2 h and 45 min. Maximum cross-
correlation coefficients were also observed when cortisol led
adiponectin by 1 h and when cortisol led sOB-R by 45 min.
Finally, the maximal cross-correlation coefficient between
cortisol and leptin appeared when cortisol led leptin by 5 h
and 30 min. sOB-R correlated most strongly with adiponec-
tin (0.60), although the highest correlation was observed
between adiponectin and cortisol (0.71). The lag periods
calculated by cross-correlation analysis were consistent with
the lag times of the trough levels during the night between
different hormones (Fig. 3). Of note, however, the cross-
correlation coefficient calculated the effect of all data points.
Therefore, it was not completely determined by the trough
level of the time series, although the trough level of the
hormone had a significant contribution.
Table 2B summarizes Spearman’s correlation coefficients
between pairs of the four analytes. Adiponectin levels cor-
related strongly and positively with sOB-R (r  0.76; P 
0.001) and cortisol (r  0.69; P  0.001), but not with leptin
levels (r  0.18; P  0.08). Cortisol and sOB-R levels also
showed significant correlation (r  0.63; P  0.001).
Ultradian variability analysis
Adiponectin and sOB-R profiles of all six subjects showed
significant pulsatility for the 15-min sampling frequency.
Cortisol and leptin profiles analyzed with the same Cluster7
parameters as those used for adiponectin and sOB-R showed
pulses with a 24-h frequency in the low range of values
reported previously (1, 21, 22). For the surrogate data, the
average number of peaks selected by the Cluster algorithm
was significantly lower than the number of peaks detected in
the original adiponectin time series (2.8  1.2 vs. 10.0  2.0;
P  0.001). This result indicates that the majority of peaks
detectedintheactualhormonetimeseriesaremostlikelynot
caused by random noise. Table 3 summarizes mean pulse
characteristics of the 24-h serum adiponectin, sOB-R, leptin,
and cortisol profiles.
Discussion
We demonstrate for the first time that serum adiponectin
exhibitsadiurnalvariationwithasignificantdeclineatnight,
reaching a nadir in the early morning. Diurnal profiles of
FIG. 2. Mean percentage changes of serum adiponectin, leptin,
sOB-R, and cortisol levels over a 24-h period beginning at 0830 h.
Hormone levels for each subject were first low-pass filtered over a
frequency range of 0–0.1 cycles/h to extract the low-frequency com-
ponents, expressed as the percentage change from their 24-h mean
value, and averaged over all six subjects. Error bars represent the SD
values of the average levels. The solid horizontal line segment indi-
cates sleeping hours during the night (2300 h-0700 h).
FIG. 3. Mean percentage changes of serum adiponectin, leptin,
sOB-R, and cortisol levels shown in Fig. 2 are plotted together to
facilitate comparison. The solid horizontal line segment indicates
sleeping hours during the night (2300 h-0700 h).
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previously. Furthermore, the 24-h variations of serum adi-
ponectin and sOB-R (23) were nearly identical and followed
thoseofcortisolafteralagperiod,butwereout-of-phasewith
leptin diurnal rhythms. We also report for the first time that
circulating adiponectin and sOB-R show evidence for an
ultradian pulsatility.
Thesimilar24-hprofilesofadiponectinandsOB-Rsuggest
that these two proteins might be under the influence of
commonregulatoryfactorsandrequirefurtherinvestigation.
Wealsofoundsimilarbutnotoverlappingdiurnalvariations
of serum adiponectin and cortisol levels. Although the two
hormones reached their maximal values around the same
time in the morning, a lag period was observed later during
the day and at night, with adiponectin reaching a nadir
approximately 2 h after cortisol. Because adiponectin in-
creases whereas cortisol decreases insulin sensitivity, one
might hypothesize that the nocturnal cortisol decline indi-
rectly determines compensatory adiponectin changes that
would tend to keep the degree of insulin resistance stable.
Our data do not provide evidence for an immediate direct
effect of cortisol on adiponectin production and secretion in
vivo in humans, however. Previous in vitro studies have
shown that glucocorticoid exposure for 16–24 h inhibits adi-
ponectinexpressionin3T3-L1andhumanmatureadipocytes
(26, 27).
Other regulatory factors could also potentially influence
serum adiponectin levels. Adrenergic tone, which decreases
early during the sleep period and then increases in the morn-
ing hours (28), has a direct inhibitory effect on adiponectin
expression and secretion in vitro (29, 30). In addition, the fact
that adiponectin starts to decrease before the sleep period in
our study may indicate that the observed adiponectin fluc-
tuations are probably not directly related to the sleep-wake
cycle. Whether adiponectin variations are associated with
sleep-wake cycles or adrenergic tone remains to be conclu-
sively shown by further studies. We also found that, similar
toapreviousstudy(9),serumadiponectinconcentrationsare
not noticeably influenced by meals, suggesting that, in vivo,
insulin does not acutely regulate adiponectin levels in hu-
mans. Insulin exposure immediately alters basal adiponectin
secretion from 3T3-L1 adipocytes in vitro (5, 31), and the lack
TABLE 1. Diurnal variation parameters of serum adiponectin, sOB-R, leptin, and cortisol levels
Parameter Adiponectin (g/ml) sOB-R (ng/ml) Leptin (ng/ml) Cortisol (g/dl)
Mean 24-h concentration 4.6  0.3 (3.7–5.7) 14.0  1.6 (9.3–19.3) 3.5  1.3 (1.4–9.4) 7.4  0.4 (5.7–8.9)
Mean peak increase (% 24-h mean) 14.9  3.7 25.4  6.4 11.6  4.8 54.9  5.9
Peak increase range (% 24-h mean) 12.3–30.1 21.1–47.0 13.4–29.9 49.2–79.3
Time at peak (h) 1100 (1000–2000) 1145 (1045–2100) 1845 (1600–0145) 1100 (0715–1315)
Mean nadir decrease (% 24-h mean) 22.6  3.1 33.9  5.4 12.5  2.8 75.1  5.7
Nadir decrease range (% 24-h mean) 14.9–35.1 25.9–52.3 10.3–25.1 60.4–98.0
Time at nadir (h) 0315 (0215–0330) 0300 (0215–0615) 0645 (0515–1530) 0115 (0015–0330)
Maximal amplitude (% 24-h mean) 37.5  6.8 59.3  11.7 24.1  7.6 130  11.5
Values are expressed as mean  SEM, and the range is presented in parentheses.
TABLE 2A. Maximum cross-correlation coefficients (Coeff) and temporal relationships between pairs of serum adiponectin, sOB-R, leptin,
and cortisol diurnal profiles
Adiponectin (g/ml) sOB-R (ng/ml) Leptin (ng/ml)
Coeff Lag period Coeff Lag period Coeff Lag period
sOB-R (ng/ml) 0.60 30 min
Leptin (ng/ml) 0.46 195 min 0.47 165 min
Cortisol (g/dl) 0.71 60 min 0.42 45 min 0.35 330 min
Positive lag period means that changes of the analyte to the left appear earlier in time. Negative lag period means that changes of the analyte
to the left appear later in time. Calculations were performed after low-pass filtering of data points (see text).
TABLE 2B. Pearson correlation coefficients (Coeff) between pairs of serum adiponectin, sOB-R, leptin, and cortisol diurnal profiles
Adiponectin (g/ml) sOB-R (ng/ml) Leptin (ng/ml)
Coeff P Coeff P Coeff P
sOB-R (ng/ml) 0.76 0.001
Leptin (ng/ml) 0.18 0.08 0.26 0.01
Cortisol (g/dl) 0.69 0.001 0.63 0.001 0.46 0.001
TABLE 3. Pulse parameters of 24-h serum adiponectin, sOB-R, leptin, and cortisol levels
Parameter Adiponectin sOB-R Leptin Cortisol
Pulse frequency/24 h 10.0  2.0 11.4  5.4 5.6  2.5 12.8  1.9
Pulse duration (min) 88.1  69.4 84.4  70.7 152.1  113.6 68.9  41.9
Pulse height 5.4  1.0 g/ml 17.7  6.6 ng/ml 4.6  0.6 ng/ml 9.5  5.7 g/dl
Pulse height (% increase) 156.0  57.9 215.3  92.3 172.8  98.6 264  230.8
Interpeak interval (min) 136.5  88.2 115.5  72.1 242.6  146.7 102.7  42.5
Interpeak concentration 4.1  1.0 g/ml 10.3  3.4 ng/ml 3.2  0.9 ng/ml 5.2  3.0 g/dl
Values are expressed as mean  SEM. Data analysis was done using the Cluster7 program (25).
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mice results in increased adiponectin expression and serum
adiponectin levels in vivo (32). However, the effect of long-
term insulin exposure on adiponectin mRNA expression re-
mains controversial (26, 27). Future studies are needed to
fully elucidate the potential effect of insulin on adiponectin
levels in vivo in humans.
In conclusion, we report evidence that circulating adi-
ponectin levels have a diurnal variation in healthy normal-
weight male human subjects. Furthermore, serum adiponec-
tin and sOB-R levels change in the same direction and at the
same time and lag behind cortisol variations by a few hours,
but are out-of-phase with leptin diurnal rhythms. Although
the observed temporal correlations do not prove the exis-
tence of a causal relationship, they raise the possibility of
significantregulationofonemoleculebytheotherorbyayet
unidentified common factor, and thus deserve further in-
vestigation. Further investigation is also needed to define
whether the apparent ultradian patterns of serum adiponec-
tin and sOB-R are related to each other and whether they are
required for biological effects. Finally, the possible influence
of gender and age, as well as effects of physiological changes
and disease states on adiponectin and other hormones in-
teracting with it warrant further study.
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